HKU team found effective anti crown drugs

[click me to see the details] Li Jiaying, a certified public accountant, is welcome to participate in the zoom tax return lecture on Thursday

.

A team from the school of medicine of the University of Hong Kong has found that the new broad-spectrum antiviral peptide “8p9r” and drugs can inhibit neocoronavirus

.

Another research team found that almost all Chinese in Hong Kong carry at least one rare genetic variation that may affect the effect of medication

.

The novel coronavirus pneumonia research team of University of Hong Kong School of medicine has discovered a new broad-spectrum antiviral therapy for novel coronavirus pneumonia

.

The team found that a bifunctional broad-spectrum antiviral peptide or a combination of clinical drugs can simultaneously inhibit the two infection pathways of the new coronavirus

.

The team said the new coronavirus can infect human cells through two ways: endocytosis and direct cell surface fusion

.

If antiviral drugs can inhibit these two infection pathways at the same time, it may achieve better inhibition effect

.

Novel coronavirus pneumonia is usually needed for years to develop specific antiviral drugs for emerging infections such as novel coronavirus pneumonia

.

Novel coronavirus pneumonia and other emerging infections are being reidentified, providing a long-term solution for rapid control of pandemic and emerging diseases in the future

.

It was found that the new conjugated peptide “8p9r” had dual function antiviral activity, and could inhibit two pathways of NCV infection at the same time

.

“8p9r” can inhibit the replication of new coronavirus in hamsters, and it is expected to continue to develop into a broad-spectrum anti disease agent to cope with the emerging diseases in the future

.

At the same time, the team identified that the combination of chloroquine, abidol and carmustistat can effectively inhibit the replication of new coronavirus in hamster lungs

.

The combination drugs identified could inhibit both the two routes of NCV infection and effectively inhibit the replication of NCV in hamsters

.

Novel coronavirus pneumonia is a strategy that may be used in clinical trials to treat patients with novel coronavirus pneumonia

.

Another research team from the school of medicine of the University of Hong Kong found that most of the Chinese in Hong Kong have at least one gene mutation related to drugs, while almost all of the Chinese in Hong Kong have at least one rare gene mutation that may affect the effect of drugs

.

Studies have shown that the development of personalized drug prescriptions through pharmacogenetics can reduce adverse reactions and enhance the efficacy potential..

.